Home > Research > Browse

Results for prostate cancer

Publications & Outputs

  1. Synthesis of bufalin derivatives with inhibitory activity against prostate cancer cells

    Yuan, X-F., Tian, H-Y., Li, J., Jin, L., Jiang, S-T., Liu, K. W-K., Luo, C., Middleton, D. A., Esmann, M., Ye, W-C. & Jiang, R-W., 3/06/2014, In: Natural Product Research. 28, 11, p. 843-847 5 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  2. The causal roles of vitamin B(12) and transcobalamin in prostate cancer: can Mendelian randomization analysis provide definitive answers?

    Collin, S. M., Metcalfe, C., Palmer, T. M., Refsum, H., Lewis, S. J., Smith, G. D., Cox, A., Davis, M., Marsden, G., Johnston, C., Lane, J. A., Donovan, J. L., Neal, D. E., Hamdy, F. C., Smith, A. D. & Martin, R. M., 2011, In: International Journal of Molecular Epidemiology and Genetics. 2, 4, p. 316-327 12 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  3. Diversity of TMPRSS2-ERG fusion transcripts in the human prostate.

    Clark, J., Merson, S., Jhavar, S., Flohr, P., Edwards, S., Foster, C. S., Eeles, R., Martin, F. L., Phillips, D. H., Crundwell, M., Christmas, T., Thompson, A., Fisher, C., Kovacs, G. & Cooper, C. S., 04/2007, In: Oncogene. 26, 18, p. 2667-2673 7 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  4. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.

    Barber, N. J., Zhang, X., Zhu, G., Pramanik, R., Barber, J. A., Martin, F. L., Morris, J. D. H. & Muir, G. H., 12/2006, In: Prostate Cancer and Prostatic Diseases. 9, 4, p. 407-413 7 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review